Glibenclamide, ATP and Metformin Increases the Expression of Human Bile Salt Export Pump ABCB11
Nisha Vats, Ravi Chandra DubeyiD, Sanal Madhusudana GirijaiD, Pankaj TanejaiD, Senthil Kumar VenugopaliD
Abstract
BackgroundBile Salt Export Pump (BSEP/ABCB11) is important in the maintenance of the enterohepatic circulation of bile acids and drugs. Drugs such as rifampicin, glibenclamide inhibit BSEP. Progressive Familial Intrahepatic Cholestasis Type-2, a lethal pediatric disease, some forms of intrahepatic cholestasis of pregnancy, and drug-induced cholestasis are associated with BSEP dysfunction. MethodsWe started with a bioinformatic approach to identify the relationship between ABCB11 and other proteins, microRNAs, and drugs. Microarray data set of the liver samples from ABCB11 knockout mice was analyzed by GEO2R tool. Differentially expressed gene pathway enrichment analysis was done by ClueGo v2.5.5 app from Cytoscape. Protein-protein interaction network was constructed by STRING application in Cytoscape. Networks were analyzed using the Cytoscape software v3.7.1. CyTargetLinker v4.1.0 was used to screen the transcription factors, microRNAs and drugs. Predicted drugs were validated on human liver cell line, HepG2. BSEP expression was quantified by Real Time PCR and Western Blot. ResultsABCB11 knockout in mice was associated with a predominant upregulation and downregulation of genes associated with cellular component movement and sterol metabolism respectively. We further identified the hub genes in the network. Genes related to immune activity, cell signaling and fatty acid metabolism were dysregulated. We further identified drugs (glibenclamide and ATP) and a total of 14 microRNAs targeting the gene. Western Blot and Real Time PCR analysis confirmed the upregulation of BSEP on the treatment of HepG2 cells with glibenclamide, ATP, and metformin. ConclusionThe differential expression of cell signaling genes and those related to immune activity in ABCB11 KO animals may be secondary to cell injury. We have found glibenclamide, ATP, and metformin upregulates BSEP. The mechanisms involved and the clinical relevance of these findings need to be investigated.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 8
- FWCI
- 0.45
- Field percentile
- top 36%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Deletion of Mcpip1 in Mcpip1AlbKO mice recapitulates the phenotype of human primary biliary cholangitis
J. Kotlinowski, T. Hutsch, … S. Chlopicki·bioRxiv·Sep 5, 2020
- A physiology-based model of bile acid metabolism shows altered tissue concentrations after drug administration and in specific genotype subgroups
Vanessa Baier, H. Cordes, … Lars Kuepfer·bioRxiv·Oct 24, 2018
- GLUCURONIDATION: THE LAST DEFENSIVE LINE AGAINST BILEACID TOXICITY DURING CHOLESTASIS.
Jocelyn Trottiet, Audrey-Anne Lavoie, … Olivier Barbier·bioRxiv·Aug 23, 2025
- Liver-specific Deletion Of Small Heterodimer Partner Alters Enterohepatic Bile Acid Levels And Promotes Bile Acid-Mediated Proliferation In Male Mice.
R. P. H. Shaw, P. Kolyvas, … S. Anakk·bioRxiv·Sep 7, 2021
- A structural and mechanistic model for BSEP dysfunction in PFIC2 cholestatic disease
Clémence Gruget, Bharat G. Reddy, Jonathan M. Moore·Communications BiologyPeer-reviewed·Apr 7, 2025
- The inositol-requiring enzyme 1α/X-box protein 1 (IRE1α/XBP1) pathway of the unfolded protein response is impaired in pediatric cholestatic liver disease explants
A. Kriegermeier, A. Hyon, … R. Green·bioRxiv·Mar 11, 2022